Private Label Buyer
Merchandising Report - Healthcare

Hungry For Health

June 15, 2012

Each month, PLBuyer brings you a different Merchandising Report, which will give you a snapshot of private label ads and key facts for a particular category or product segment.

This issue looks at what’s happening in the healthcare category.

See the various healthcare products CVS, Rite Aid, Walgreens and Target were featuring in their ad circulars during March.

Also, scan some key facts on the healthcare category.

These monthly reports are compiled with data supplied by Chicago-based research firm Market Track, and Mintel International Group, Ltd.

FEATURED HEALTHCARE PRODUCTS:

antacid cvs pharmacy sale

BUFFALO, N.Y.

CVS was offering CVS brand antacid tablets for $2.99 with a CVS card in mid-March.

 

rite aid sale ibuprofen acetaminophen

ATLANTA, GA.

Rite Aid was advertising buy one, get the second one free on its Rite Aid brand acetaminophen, ibuprofen, naproxen sodium and children’s or infant’s acetaminophen or ibuprofen in mid-March.

 

walgreens sale allergy medicine

CINCINNATI, OHIO

Walgreens was offering its Wal-Fex, Wal-Zyr or Wal-itin allergy relief medications for $9.99 with $3 in Register Rewards in mid-March.

 

sale ad target private lable

ANAHEIM, CALIF.

Target was featuring its up & up brand multipurpose solution or eye drops for $2.99 in mid-March.

 

HEALTHCARE FACTS

U.S. MARKET SIZE: $2.5 billion for OTC internal analgesics in 2010; $2.5 billion for gastrointestinal remedies in 2010.

 

GROWTH PROSPECTS: 15.3 % growth projected, 2011 through 2014 for OTC internal analgesics.  15.7 % growth expected, 2011 through 2014 for gastrointestinal remedies.

 

WHAT SELLS: The share of private label products in the overall OTC analgesic market increased by 3.8 share points from 2005-09. The gain by PL was even more severe in 2010, due to widespread Tylenol recalls. Private label sales saw a significant boost from the initial release of private label versions of Prilosec and Pepcid Complete in 2008. Private label versions of Miralax hit shelves in 2009.